• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 26 of 100
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
Health
Pfizer’s vaccine didn’t just ward off COVID—it may have saved Germany’s economy last year
By Christiaan HetznerJanuary 21, 2022
Mark Cuban opens his own online pharmacy
Health
Mark Cuban opens his own online pharmacy
By Chris MorrisJanuary 20, 2022
Biogen building
Health
Medicare ordered to reassess premium hike for Alzheimer’s drug
By Ricardo Alonso-Zaldivar and The Associated PressJanuary 10, 2022
Gloved hand holding pills in front of Sanofi corporate logo
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
World leaders should acknowledge that IP protections facilitate vaccine access
Commentary
World leaders should acknowledge that IP protections facilitate vaccine access
By Andrei IancuDecember 24, 2021
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
By Suzi Ring and BloombergDecember 23, 2021
Del-Kar Pharmacy owner Edwin Muldrow
Health
One Chicago pharmacy avoids creating another drugstore desert by tapping into its deep roots
By Markian Hawryluk and Kaiser Health NewsDecember 22, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Biogen headquarters
Health
Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval
By Timothy Annett and BloombergDecember 20, 2021
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
Health
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
By The Associated PressDecember 8, 2021
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health
Omicron vaccine to begin clinical trial in South Africa
By Jeremy KahnDecember 6, 2021
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
Commentary
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
The most important meeting yet for global pandemic response—and drugmakers
Commentary
The most important meeting yet for global pandemic response—and drugmakers
By Nicole Hassoun and Kaushik BasuNovember 29, 2021
To avoid the superbug pandemic, we must fix the business model for new antibiotics
Commentary
To avoid the superbug pandemic, we must fix the business model for new antibiotics
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
1...
  • 24
  • 25
  • 26
  • 27
  • 28
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.